SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise SPME Q1 2026 Earnings Preferred Shares Miss EPS Estimates Stock Declines ACMR Q1 2026 Earnings EPS Surges Past Estimates as Operational Efficiency Drives Profitability ABNB Q1 2026 Earnings EPS Falls Short as Stock Dips Modestly NICE Q1 2026 Earnings EPS Beats Estimates Amid Mixed Market Reaction MRDN Q1 2026 Earnings Massive EPS Beat Surprises Market